Log In
Print
BCIQ
Print
Print this Print this
 

Leukine, sargramostim

Also known as: Granulocyte macrophage-colony stimulating factor (GM-CSF)

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionYeast-derived GM-CSF
Molecular Target Granulocyte macrophage colony-stimulating factor (GM-CSF) receptor (CSF2RA) (GMR) (CD116)
Mechanism of ActionGranulocyte macrophage colony stimulating factor (GM-CSF) receptor agonist
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$5,800.0M

$100.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today